Abstract: An atomic layer deposition method for manufacturing a platinum-based alloy catalyst includes applying a support in a reactor and depositing an alloy of platinum and a non-platinum metal on the support through a super cycle comprising a first sub-cycle and a second sub-cycle.

Abstract: The present disclosure relates to a composite cable for a vehicle and a composite cable assembly, which are capable of simultaneously providing a communication function and power to an electronic parking brake (EPB) and an anti-lock brake system (ABS) for use in a vehicle, and maximizing electromagnetic compatibility (EMC) shielding performance between internal components or external cables.

Abstract: A method of personalizing a vehicle lamp includes drawing an image made up of a plurality of pixels that implement a vehicle lamp, based on an input by a user. The method also includes converting the drawn image into light-and-shade data that correspond to the pixels, respectively, multiplying a pixel light distribution value, corresponding to each pixel, by a weighted value based on the data resulting from the conversion, adding up results of the multiplication, and deriving total light distribution of the pixels that results when brightness of the vehicle lamp is the same as that of the drawn image. The method further includes comparing the derived total light distribution against a predetermined reference value and determining whether the derived total light distribution satisfies a predetermined light distribution reference, and applying the drawn image to the vehicle lamp when it is determined that a predetermined light distribution reference is satisfied.

Abstract: A fastening component supplying apparatus is disclosed. The disclosed fastening component supplying apparatus according to an exemplary embodiment of the present invention for supplying a plurality of bolts aligned by a bolt aligning device to a fastening portion of a fastening target part includes: a bolt picking unit rotatably installed to an arm front end of a handling robot and picking a plurality of bolts aligned in the bolt aligning device; and a bolt drop unit installed to an arm front end side of the handling robot and dropping the bolts picked by the bolt picking unit to the fastening portion.

Abstract: An engagement component supplying apparatus includes: i) a jig frame in which at least one driving unit is installed and which is configured to support an engagement target part and a corresponding part to be engaged each other through a plurality of engagement components; ii) an engagement component picking unit installed on the at least one driving unit through a mounting bracket and which is configured to pick the plurality of engagement components aligned at a predetermined position; and iii) an engagement component temporary engagement unit installed on the mounting bracket and which is configured to, while picking the plurality of engagement components picked by the engagement component picking unit one by one, temporarily engage the plurality of engagement components to a plurality of second engagement portions of the corresponding part through a plurality of first engagement portions of the engagement target part.

Abstract: A part assembling system of an automation line includes: a station frame in which a part assembling tool is installed and that includes at least one mounting part; at least one positioner mounted on the at least one mounting part; a part conveying pallet including at least one positioning pin coupled to the at least one positioner; and a moving carriage that transports the part conveying pallet to a predetermined position on a floor of a process work area.

Abstract: An Ethernet cable that includes a pair of cores including a single-wire conductor and an insulator covering the single-wire conductor; and an armoring layer entirely covering the pair of cores, wherein the pair of cores are twisted together to have a twist pitch (P1) in a cable length direction satisfying certain characteristics.

Abstract: The pharmaceutical composition according to the present invention contains the active ingredient dimethyl fumarate or monomethyl fumarate or a pharmaceutically acceptable salt thereof in a specific dose, and exhibits specific pharmacokinetic parameters when administered into the body. In addition, the pharmaceutical composition of the present invention has proven its efficacy and safety in type 2 diabetic nephropathy patients with albuminuria, and thus can be effectively used as a preventive or therapeutic agent for diabetic nephropathy.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating chronic kidney disease, the composition including graphene quantum dots as an active ingredient. Graphene quantum dots according to the present invention were observed to exhibit the effects of decreasing the expression of fibronectin, collagen 1al, Bax, TGF-?1, Smad2/3, ?-SMA, etc., which are renal fibrosis-related proteins, and increasing the expression of E-cadherin, Smad7, MnSOD, and SOD1, and thereby suppress renal fibrosis. Accordingly, it is expected that the graphene quantum dots according to the present invention will be able to be effectively used in the field of developing agents for treating or alleviating chronic kidney disease caused by renal fibrosis.

Abstract: A semiconductor manufacturing apparatus includes a loadlock module including a loadlock chamber in which a substrate container is received, wherein the loadlock module is configured to switch an internal pressure of the loadlock chamber between atmospheric pressure and a vacuum; and a transfer module configured to transfer a substrate between the substrate container received in the loadlock chamber and a process module for performing a semiconductor manufacturing process on the substrate, wherein the loadlock module includes a purge gas supply unit configured to supply a purge gas into the substrate container through a gas supply line connected to the substrate container; and an exhaust unit configured to discharge a gas in the substrate container through an exhaust line connected to the substrate container.

Abstract: A part assembling system of an automation line includes: a station frame in which a part assembling tool is installed and that includes at least one mounting part; at least one positioner mounted on the at least one mounting part; a part conveying pallet including at least one positioning pin coupled to the at least one positioner; and a moving carriage that transports the part conveying pallet to a predetermined position on a floor of a process work area.

Abstract: A display device includes a display substrate including a display area and a pad area located around the display area, a plurality of light emitting elements located on the display area of the display substrate, a plurality of pads located on the pad area of the display substrate and connected to the plurality of light emitting elements, a flexible film attached to the display substrate, a plurality of lead wires disposed on the flexible film, and an anisotropic conductive film disposed between the display substrate and the flexible film. The anisotropic conductive film is disposed between each of the plurality of pads and a corresponding one of the plurality of lead wires overlapping each other to form an electrical connection therebetween. The flexible film has a light transmittance of 60% or more with respect to a visible light wavelength range.

Abstract: A plasma processing apparatus includes a process chamber having an inner space, an electrostatic chuck in the process chamber and to which a substrate is mounted, a gas injection unit to inject a process gas into the process chamber at a side of the process chamber, a plasma applying unit to transform the process gas injected into the process chamber into plasma, and a plasma adjusting unit disposed around the electrostatic chuck and operative to adjust the density of the plasma across the substrate.

Abstract: The present invention relates to a crystalline form Of (E)-methyl 6-((3S,8S,9S,10R,13S,14S,17R)-3-(((5S,6R)-5-acetoxy -6-(acetoxytnethyl)-5,6-dihydro-2H-pyran-2-yl)oxy)-10,13 -dimethyl-2,3,4,7,8,9,10.11,12,13,14,15,16,17-tetradecahydro -1H-cyclopenta [a]phenanthrene-17-yl)hept-5-enoate and a blood vessel leak blocker comprising the same. The novel crystalline form has high purity, excellent stability, excellent long-term storage and pharmaceutical stability, and can be used as a vascular leakage blocker, so it is very advantageous in producing high-quality drug substances.

Abstract: The present invention relates to a novel tryptophan hydroxylase inhibitor and a pharmaceutical composition including same, wherein the novel tryptophan hydroxylase inhibitor has an excellent inhibitory effect on TPH1, and thus can be usefully used for the prevention or treatment of disorders, such as metabolic disorders, cancer, digestive or cardiovascular system disorders, related to TPH1 activity. In particular, the novel tryptophan hydroxylase inhibitor has an excellent treatment effect on inflammatory bowel disorders, and thus can be usefully used for the treatment of inflammatory bowel disorder.

Abstract: The present disclosure relates to a composite cable for a vehicle and a composite cable assembly, which are capable of simultaneously providing a communication function and power to an electronic parking brake (EPB) and an anti-lock brake system (ABS) for use in a vehicle, and maximizing electromagnetic compatibility (EMC) shielding performance between internal components or external cables.

Abstract: The present invention relates to a cancer immunotherapy adjuvant, wherein the adjuvant, when administered in combination with a cancer immunotherapy agent, activates the function of immune factors without causing in vivo side effects, to exhibit the effect of enhancing the kit for anticancer effect of the cancer immunotherapy agent, and thus can be effectively used as a cancer immunotherapy adjuvant.

Abstract: Provided is an Ethernet cable. Specifically, the present disclosure relates to an Ethernet cable that is excellent in durability and electrical characteristics due to high flexibility and resistance to vibration and that may be manufactured at low costs.

Abstract: The present invention relates to: a biodegradable capsule which is a capsule having a form in which a capsule wall surrounds fragrance or oil, wherein a polymer, formed by the reaction of a fibrous polymer, a protein polymer, an aliphatic polyesterpolyol and an aliphatic crosslinking agent, constitutes the capsule wall of the capsule; and a manufacturing thereof.

Abstract: A plasma processing device is provided with a chamber including a space that is configured to perform a treatment process for a wafer. A supporting member is disposed inside of the chamber and configured to support the wafer. A gas supply unit is configured to inject a mixed gas in different directions toward the supporting member. The pressure of the mixed gas is increased by adding inert gas to reactive gas.